Closed
Element Biosciences AVITI¿ 24 sequencing and spati
- NAICS
- 334516
- Closed
- Aug 13, 2026
- Posted
- Aug 11, 2026
Description
The purpose of this acquisition is to enhance the shared research capabilities of the National Cancer Institute (NCI), Center for Cancer Research (CCR), by acquiring an Element Biosciences AVITI24 Sequencing System for joint operation by the CCR Genomics Core and the CCR High-Throughput Imaging Facility (HiTIF).
Track this market for the recompete
This opportunity has closed. Follow NAICS 334516 and we'll alert you when the follow-on contract posts.